Strength Cancer Research Results
Strength, physical strength: Click to Expand ⟱
| Source: |
| Type: |
Physical strength
|
Scientific Papers found: Click to Expand⟱
Strength↑, *Casp3↓, cachexia↓, *Dose↝,
| - |
in-vivo, |
Ovarian, |
A2780S |
|
|
|
*cachexia↑, *UPR↑, Strength↑,
PleEff↓, breath↑, Pain↓, Appetite↑, Strength↑, BowelM↑, OS↑,
AntiCan↑, breath↑, Pain↓, Appetite↑, Strength↑, BowelM↑, TumMeta↓, TumCCA↑, ETC↓, MMP↓, TumCD↑, selectivity↑, ROS↑, Casp3↑, TumCG↓, TumCCA↑, ChrMod↑, TumMeta↓, Imm↑, DCells↑, Akt↓, OS⇅, toxicity↓, QoL↑, hepatoP↑, Pain↓, Weight↑, Strength↑, Sleep↑, IL6↓, CD4+↑, CD8+↑, Ca+2↑, radioP↑, chemoP↑, *BMD↑, *AntiAge↑, *AMPK↑, *P21↓, *P53↓, *mTOR↓, *OS↑, *β-Endo↑, *5HT↓,
| - |
in-vivo, |
GC, |
HL-60 |
|
|
|
- |
in-vivo, |
GC, |
SK-HEP-1 |
|
|
|
OS↑, Pain↓, ChemoSideEff↓, Weight↑, Strength↑, Sleep↑,
| - |
in-vitro, |
PC, |
AsPC-1 |
|
|
|
- |
in-vivo, |
PC, |
NA |
|
|
|
- |
in-vitro, |
PC, |
MIA PaCa-2 |
|
|
|
- |
in-vitro, |
PC, |
PANC1 |
|
|
|
- |
in-vitro, |
PC, |
Bxpc-3 |
|
|
|
TumCG↓, Glycolysis↓, cMyc↓, STAT3↓, TumCP↓, Weight∅, Strength↑, DNAdam↑, Casp3↑, Casp9↑, GLUT1↓, HK2↓, LDHA↓, GlucoseCon↓, lactateProd↓, PPP↓, Ki-67↓, p‑STAT3↓, cachexia↓,
Pain↓, Strength↑, QoL↑, Dose∅,
| - |
in-vitro, |
BC, |
MDA-MB-231 |
|
|
|
- |
in-vitro, |
AML, |
RAW264.7 |
|
|
|
BMD↑, YAP/TEAD↑, TumCG↓, Strength↑, TumCI↓, Fas↑, Ca+2↑,
Showing Research Papers: 1 to 8 of 8
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 8
Pathway results for Effect on Cancer / Diseased Cells:
Redox & Oxidative Stress(tgid=1) ⓘ
ROS↑, 1,
Mitochondria & Bioenergetics(tgid=3) ⓘ
ETC↓, 1, MMP↓, 1, PleEff↓, 1,
Core Metabolism/Glycolysis(tgid=4) ⓘ
cMyc↓, 1, GlucoseCon↓, 1, Glycolysis↓, 1, HK2↓, 1, lactateProd↓, 1, LDHA↓, 1, PPP↓, 1,
Cell Death(tgid=5) ⓘ
Akt↓, 1, Casp3↑, 2, Casp9↑, 1, Fas↑, 1, TumCD↑, 1, YAP/TEAD↑, 1,
Transcription & Epigenetics(tgid=7) ⓘ
BowelM↑, 2, ChrMod↑, 1,
DNA Damage & Repair(tgid=10) ⓘ
DNAdam↑, 1,
Cell Cycle & Senescence(tgid=11) ⓘ
TumCCA↑, 2,
Proliferation, Differentiation & Cell State(tgid=12) ⓘ
STAT3↓, 1, p‑STAT3↓, 1, TumCG↓, 3,
Migration(tgid=13) ⓘ
Ca+2↑, 2, Ki-67↓, 1, TumCI↓, 1, TumCP↓, 1, TumMeta↓, 2,
Barriers & Transport(tgid=15) ⓘ
GLUT1↓, 1,
Immune & Inflammatory Signaling(tgid=16) ⓘ
CD4+↑, 1, DCells↑, 1, IL6↓, 1, Imm↑, 1,
Drug Metabolism & Resistance(tgid=21) ⓘ
Dose∅, 1, selectivity↑, 1,
Clinical Biomarkers(tgid=22) ⓘ
BMD↑, 1, IL6↓, 1, Ki-67↓, 1,
Functional Outcomes(tgid=23) ⓘ
AntiCan↑, 1, Appetite↑, 2, breath↑, 2, cachexia↓, 2, chemoP↑, 1, ChemoSideEff↓, 1, hepatoP↑, 1, OS↑, 2, OS⇅, 1, Pain↓, 5, QoL↑, 2, radioP↑, 1, Sleep↑, 2, Strength↑, 9, toxicity↓, 1, Weight↑, 2, Weight∅, 1,
Infection & Microbiome(tgid=24) ⓘ
CD8+↑, 1,
Total Targets: 57
Pathway results for Effect on Normal Cells:
Core Metabolism/Glycolysis(tgid=4) ⓘ
AMPK↑, 1,
Cell Death(tgid=5) ⓘ
Casp3↓, 1,
Protein Folding & ER Stress(tgid=8) ⓘ
UPR↑, 1,
DNA Damage & Repair(tgid=10) ⓘ
P53↓, 1,
Cell Cycle & Senescence(tgid=11) ⓘ
P21↓, 1,
Proliferation, Differentiation & Cell State(tgid=12) ⓘ
mTOR↓, 1,
Migration(tgid=13) ⓘ
β-Endo↑, 1,
Synaptic & Neurotransmission(tgid=18) ⓘ
5HT↓, 1,
Drug Metabolism & Resistance(tgid=21) ⓘ
Dose↝, 1,
Clinical Biomarkers(tgid=22) ⓘ
BMD↑, 1,
Functional Outcomes(tgid=23) ⓘ
AntiAge↑, 1, cachexia↑, 1, OS↑, 1,
Total Targets: 13
Scientific Paper Hit Count for: Strength, physical strength
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:0 prod#:% Target#:578 State#:% Dir#:2
wNotes=0 sortOrder:rid,rpid
Home Page